Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2).

Tran, Ai Phuong; Tassone, D F; Ding, N S; Nossent, Johannes

Tran, Ai Phuong; Tassone, D F; Ding, N S; Nossent, Johannes.

Afiliación

Tran AP; Department of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia ai.tran@research.uwa.edu.au.
Tassone DF; St John of God Private Hospital, Murdoch, Western Australia, Australia.
Ding NS; The University of Melbourne, Melbourne, Victoria, Australia.
Nossent J; Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.

RMD Open ; 9(1)2023 03.

Article en En | MEDLINE | ID: mdl-36863751

Asunto(s)

Antirreumáticos; COVID-19; Vacunas; Humanos; Formación de Anticuerpos; ARN Viral; COVID-19/prevención & control; SARS-CoV-2

Palabras clave

Autoimmune Diseases; COVID-19; Immune System Diseases; Vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / Antirreumáticos / COVID-19 Límite: Humans Idioma: En Revista: RMD Open Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google